Author: admin

SUZHOU, China, Oct. 16, 2024 /PRNewswire/ — TenNor Therapeutics, a clinical stage company dedicated to developing new therapies to address unmet needs in infectious diseases, announced today the initial closing of a Series E financing round for more than 300 million RMB. New investor AMR Actio

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: